Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary peritoneal cancer (ANZGOG1901/2020)

BACKGROUND: Ovarian cancer is the most lethal gynecological cancer, causing over 200,000 deaths worldwide in 2020. Initial standard treatment for primary ovarian cancer is optimal cytoreductive surgery (CRS) preceded and/or followed by intravenous platinum-based chemotherapy. However, most women dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Farrell, Rhonda, Burling, Michael, Lee, Yeh Chen, Pather, Selvan, Robledo, Kristy, Mercieca-Bebber, Rebecca, Stockler, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2021
Materias:
Clinical Trial Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728663/
https://www.ncbi.nlm.nih.gov/pubmed/34783204
http://dx.doi.org/10.3802/jgo.2022.33.e1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728663/
https://www.ncbi.nlm.nih.gov/pubmed/34783204
http://dx.doi.org/10.3802/jgo.2022.33.e1

Ejemplares similares